Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yasin Tülüce

11PUBLICATIONS

11CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsExercise physiologyBiomolecular modelling and design

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Sep 03, 2025

Therapeutic Potential of CAPE in Targeting Hallmarks of Cancer in TPC-1 Thyroid Cancer Cells Through Modulation of Mitochondrial Membrane Potential.

Yasin Tülüce, Hümeyra Bucak, Sedat Köstekci

|Mar 19, 2025

Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8<sup>+</sup> co-culture model.

Yasin Tülüce, Sedat Köstekci, Fuat Karakuş

|Jan 05, 2025

Investigation of potential anti-metastatic effect of metformin and caffeic acid combination therapy in breast cancer cell line in in-vitro culture model.

Halil Yavuz, Yasin Tülüce, Fuat Karakuş

|Dec 03, 2024

Evaluation of the toxicity potential of exercise and atorvastatin/metformin combination therapy on STZ-diabetic rats.

Merve Tunçyürekli, Yasin Tülüce, Ferzan Lermioglu Erciyas

|Jul 26, 2024

Protective Action of Curcumin and Alpha-lipoic Acid, Against Experimental Ultraviolet-A/B Induced Dermal-injury in Rats.

Yasin Tülüce, Derya Osmanoğlu, Murat Çetin Rağbetli

|May 29, 2024

Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.

Fuat Karakuş, Burak Kuzu, Sedat Köstekci

Pageof 2

Frequent Collaborators

4 joint publications

Sedat Köstekci

3 joint publications

Fuat Karakuş

3 joint publications

Merve Tunçyürekli

2 joint publications

Ahmet Yasin Keleş

1 joint publications

Necati Muhammed Tat

1 joint publications

Mehmet Kara

1 joint publications

Ayşe Merve Tat

1 joint publications

Burak Kuzu

1 joint publications

Ferzan Lermioglu Erciyas

1 joint publications

Halil Yavuz

Frequent Collaborators

4 joint publications

Sedat Köstekci

3 joint publications

Fuat Karakuş

3 joint publications

Merve Tunçyürekli

2 joint publications

Ahmet Yasin Keleş

Top Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on : May 30, 2012

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on : Jun 20, 2015

See more related videos

Top Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on : May 30, 2012

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on : Jun 20, 2015

See more related videos